The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.

Research changed Kelsey's life. Your support can change another. LEARN MORE

Publication PMID: 30137587

Bermas BL, Tassinari M, Clowse M, Chakravarty E. The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy. Rheumatology (Oxford) 57:v2-v8, 2018 July, PMID: 30137587, PMCID: PMC6099131

Publication PMID: 30137587

Before Footer

Footer